Backgrounds/Aims: Intraductal papillary mucinous neoplasm (IPMN) of the pancreas has malignant potential. Predicting invasive IPMN has proven difficult and controversial. We tried to identify predictive factors for invasive IPMN. Methods: Thirty six patients underwent resection for IPMN from February 2001 to July 2011. Clinicopathological features including demographic, imaging, microscopic, and serological findings were retrospectively reviewed. Receiver operating characteristic (ROC) curve analysis was used to analyze sensitivity and specificity of all possible cut-off values for the diameter of the main pancreatic duct and mass size predicting invasive IPMN. Student t-test, chi-square test, and logistic regression were used for univariate and multivariate analysis. Results: The mean age was 63.5±8.4 years. Males were more commonly affected (58.3% vs 41.7%). Pancreaticoduodenectomy was performed in 55.6% of patients, distal pancreatectomy in 36.1%, and central pancreatic resection in 8.3%. Non-invasive IPMNs were present in 80.6% (n=29), whereas invasive IPMNs were present in 19.4% (n=7). In univariate analysis, tumor location (p=0.036), Kuroda classification (p=0.048), mural nodule (p=0.016), and main duct dilatation (≥8 mm) (p=0.006) were statistically significant variables. ROC curve analysis showed that a value of 8 mm for the main duct dilatation and a value of 35 mm for the size of the mass lesion have 80% sensitivity and 75% specificity and 100% sensitivity and 82.6% specificity, respectively. However, in multivariate analysis, main ductal dilatation (≥8 mm) was identified to be the only independent factor for invasive IPMN (p=0.049). Conclusions: Main duct dilatation appears to be a useful indicator for predicting invasive IPMN. 
INTRODUCTION
Intraductal papillary mucinous neoplasm (IPMN) of the pancreas is a distinct entity characterized by papillary proliferations of mucin-producing epithelial cells with excessive mucus production and cystic dilatation of the pancreatic ducts. IPMN was first described by Ohashi et al.
in 1982 and first recognized in the World Health Organization classification in 1996. 1 IPMNs histologically show a broad spectrum ranging from adenoma to invasive carcinoma with different degrees of severity and seem to follow a progression from adenoma to invasive, similar to the well-defined adenoma-carcinoma sequence in colorectal cancer and pancreatic ductal adenocarcinoma (pancreatic intraepithelial neoplasia [PanIN] to invasive ductal carcinoma). 2, 3 Although prognosis for IPMN is better than that for ductal adenocarcinoma because IPMNs grow slowly and are diagnosed earlier than ductal adenocarcinoma, invasively transformed IPMNs have poor outcomes, similar to ductal adenocarcinoma. Thus, discriminating invasive IPMN from non-invasive IPMN is important for the choice of appropriate management of patients with
IPMNs.
The purpose of this study was to determine predictive factors of invasive IPMN by examining and analyzing 
Fig. 1.
Receiver operating characteristic curve analysis for cut-off values of the diameter of the main pancreatic duct and mass size. Using 7 mm as a cut-off level for the main duct diameter yielded a sensitivity of 100% and a specificity of 63%; 8 mm yielded a sensitivity of 80% and a specificity of 75% (A). Using 35 mm as a cut-off level for the size of the mass yielded a sensitivity of 100% and a specificity of 82.6% (B).
Receiver operating characteristic curve analysis for cut-off values for the diameter of the main pancreatic duct and mass size ROC curve analysis for cut-off values of the diameter of the main pancreatic duct and mass size was performed using data from the different patients group. ROC curve analysis for duct dilatation was done in 13 patients with duct dilatation excluding pure branch duct type IPMN.
Using 7 mm as a cut-off level for the main duct diameter yielded a sensitivity of 100% and a specificity of 63%, whereas 8 mm yielded a sensitivity of 80% and a specifi city of 75% (Fig. 1A) . For the size of the mass lesion, ROC curve analysis was done in 26 patients with any measurable lesion dilatation excluding pure main duct type IPMN. Using 35 mm as a cut-off level for the size of the mass yielded a sensitivity of 100% and a specificity of 82.6% (Fig. 1B) . Table 2) . ROC curve analysis yielded optimal cut-off values for the diameter of the main pancreatic duct and mass size.
Since an 8 mm diameter of the main pancreatic duct yielded high sensitivity (80%) and specificity (75%), we Multivariate analysis between non-invasive IPMN and invasive IPMN A multivariate analysis was performed to determine the independent predictors of invasive IPMN. The parameters of tumor size (＜35 versus ≥35 mm), main duct dilatation (＜8 versus ≥8 mm), symptoms (absent versus present), and mural nodules (absent versus present) were put into the binary logistic regression model. It showed that tumor size and mural nodule did not reach statistical significance. Among the factors verified by univariate analysis, main duct dilatation (≥8 mm) was the only significant factor predicting invasive IPMN (p=0.049) ( Table   3 ). in the main pancreatic duct and a solid mass in pancreatic parenchyma were reported to be associated with invasive disease. 11, [20] [21] [22] In the present study, we tried to determine the sensi- In conclusion, IPMN is a premalignant lesion. It is important to distinguish invasive carcinoma from non-invasive IPMN. Our study showed that main duct dilatation ≥8 mm can be a useful indicator for predicting invasive IPMN.
DISCUSSION

